BACKGROUND AND PURPOSE: The implementation of uniform nomenclature and classification in adult arterial ischemic stroke (AIS) has been critical for defining outcomes and recurrence risks according to etiology and in developing risk-stratified treatments. In contrast, current classification and nomenclature in childhood AIS are often overlapping or contradictory. Our purpose was to develop a comprehensive consensus-based classification system for childhood AIS. METHODS: Using a modified-Delphi method, members of the International Pediatric Stroke Study (IPSS) developed the Childhood AIS Standardized Classification And Diagnostic Evaluation (CASCADE) criteria. Two groups of pediatric stroke specialists from the IPSS classified 7 test cases using 2 methods each: (1) classification typical of the individual clinician's current clinical practice; and (2) classification based on the CASCADE criteria. Group 1 underwent in-person training in the utilization of the CASCADE criteria. Group 2 classified the same cases via an online survey, including definitions but without training. Inter-rater reliability (IRR) was assessed via multi-rater unweighted κ-statistic. RESULTS: In Group 1 (with training), IRR was improved using CASCADE criteria (κ=0.78, 95% CI=[0.49, 0.94]), compared with typical clinical practice (κ=0.40, 95% CI=[0.11, 0.60]). In Group 2 (without training), IRR was lower than among trained raters (κ=0.61, 95% CI=[0.29, 0.77]), but higher than current practice (κ=0.23, 95% CI=[0.03, 0.36]). CONCLUSIONS: A new, consensus-based classification system for childhood AIS, the CASCADE criteria, can be used to classify cases with good IRR. These preliminary findings suggest that the CASCADE criteria may be particularity useful in the setting of prospective multicenter studies in childhood-onset AIS, where standardized training of investigators is feasible.
BACKGROUND AND PURPOSE: The implementation of uniform nomenclature and classification in adult arterial ischemic stroke (AIS) has been critical for defining outcomes and recurrence risks according to etiology and in developing risk-stratified treatments. In contrast, current classification and nomenclature in childhood AIS are often overlapping or contradictory. Our purpose was to develop a comprehensive consensus-based classification system for childhood AIS. METHODS: Using a modified-Delphi method, members of the International Pediatric Stroke Study (IPSS) developed the Childhood AIS Standardized Classification And Diagnostic Evaluation (CASCADE) criteria. Two groups of pediatric stroke specialists from the IPSS classified 7 test cases using 2 methods each: (1) classification typical of the individual clinician's current clinical practice; and (2) classification based on the CASCADE criteria. Group 1 underwent in-person training in the utilization of the CASCADE criteria. Group 2 classified the same cases via an online survey, including definitions but without training. Inter-rater reliability (IRR) was assessed via multi-rater unweighted κ-statistic. RESULTS: In Group 1 (with training), IRR was improved using CASCADE criteria (κ=0.78, 95% CI=[0.49, 0.94]), compared with typical clinical practice (κ=0.40, 95% CI=[0.11, 0.60]). In Group 2 (without training), IRR was lower than among trained raters (κ=0.61, 95% CI=[0.29, 0.77]), but higher than current practice (κ=0.23, 95% CI=[0.03, 0.36]). CONCLUSIONS: A new, consensus-based classification system for childhood AIS, the CASCADE criteria, can be used to classify cases with good IRR. These preliminary findings suggest that the CASCADE criteria may be particularity useful in the setting of prospective multicenter studies in childhood-onset AIS, where standardized training of investigators is feasible.
Authors: Mark T Mackay; Max Wiznitzer; Susan L Benedict; Katherine J Lee; Gabrielle A Deveber; Vijeya Ganesan Journal: Ann Neurol Date: 2011-01 Impact factor: 10.422
Authors: Susanne M Benseler; Gabrielle deVeber; Cynthia Hawkins; Rayfel Schneider; Pascal N Tyrrell; Richard I Aviv; Derek Armstrong; Ronald M Laxer; Earl D Silverman Journal: Arthritis Rheum Date: 2005-07
Authors: Timothy J Bernard; Lauren A Beslow; Marilyn J Manco-Johnson; Jennifer Armstrong-Wells; Richard Boada; David Weitzenkamp; Amanda Hollatz; Sharon Poisson; Catherine Amlie-Lefond; Warren Lo; Gabrielle deVeber; Neil A Goldenberg; Michael M Dowling; E Steve Roach; Heather J Fullerton; Susanne M Benseler; Lori C Jordan; Adam Kirton; Rebecca N Ichord Journal: Stroke Date: 2016-09-15 Impact factor: 7.914
Authors: Zak Ritchey; David M Mirsky; David Weitzenkamp; Timothy J Bernard; Paco S Herson; Nicholas V Stence Journal: Childs Nerv Syst Date: 2018-12-08 Impact factor: 1.475
Authors: Peter B Sporns; Ronald Sträter; Jens Minnerup; Heinz Wiendl; Uta Hanning; René Chapot; Hans Henkes; Elina Henkes; Astrid Grams; Franziska Dorn; Omid Nikoubashman; Martin Wiesmann; Georg Bier; Anushe Weber; Gabriel Broocks; Jens Fiehler; Alex Brehm; Marios Psychogios; Daniel Kaiser; Umut Yilmaz; Andrea Morotti; Wolfgang Marik; Richard Nolz; Ulf Jensen-Kondering; Bernd Schmitz; Stefan Schob; Oliver Beuing; Friedrich Götz; Johannes Trenkler; Bernd Turowski; Markus Möhlenbruch; Christina Wendl; Peter Schramm; Patricia Musolino; Sarah Lee; Marc Schlamann; Alexander Radbruch; Nicole Rübsamen; André Karch; Walter Heindel; Moritz Wildgruber; André Kemmling Journal: JAMA Neurol Date: 2020-01-01 Impact factor: 18.302
Authors: Max Wintermark; Nancy K Hills; Gabrielle A deVeber; A James Barkovich; Mitchell S V Elkind; Katherine Sear; Guangming Zhu; Carlos Leiva-Salinas; Qinghua Hou; Michael M Dowling; Timothy J Bernard; Neil R Friedman; Rebecca N Ichord; Heather J Fullerton Journal: Stroke Date: 2014-11-11 Impact factor: 7.914
Authors: Paco S Herson; Chris G Bombardier; Susan M Parker; Takeru Shimizu; Jost Klawitter; Jelena Klawitter; Nidia Quillinan; Jennifer L Exo; Neil A Goldenberg; Richard J Traystman Journal: Stroke Date: 2013-01-24 Impact factor: 7.914
Authors: Neil A Goldenberg; Timothy J Bernard; Jasper Hillhouse; Jennifer Armstrong-Wells; Jeffrey Galinkin; Rhonda Knapp-Clevenger; Linda Jacobson; Santica M Marcovina; Marilyn J Manco-Johnson Journal: Haematologica Date: 2013-01-24 Impact factor: 9.941